1. Home
  2. PASG vs UG Comparison

PASG vs UG Comparison

Compare PASG & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASG

Passage Bio Inc.

N/A

Current Price

$6.89

Market Cap

26.0M

Sector

Health Care

ML Signal

N/A

Logo United-Guardian Inc.

UG

United-Guardian Inc.

N/A

Current Price

$6.25

Market Cap

30.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
PASG
UG
Founded
2017
1942
Country
United States
United States
Employees
27
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
30.2M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
PASG
UG
Price
$6.89
$6.25
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$23.50
N/A
AVG Volume (30 Days)
31.7K
2.8K
Earning Date
03-03-2026
05-07-2026
Dividend Yield
N/A
8.05%
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
N/A
$12,181,971.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$31.05
Revenue Growth
N/A
11.91
52 Week Low
$0.28
$5.58
52 Week High
$20.00
$9.88

Technical Indicators

Market Signals
Indicator
PASG
UG
Relative Strength Index (RSI) 37.13 41.96
Support Level $6.71 $5.58
Resistance Level $7.72 $6.78
Average True Range (ATR) 0.69 0.16
MACD 0.01 -0.03
Stochastic Oscillator 13.59 23.29

Price Performance

Historical Comparison
PASG
UG

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: